These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31079699)

  • 21. Pharmacogenomics of beta-adrenergic receptors and their accessory signaling proteins in heart failure.
    Dorn GW; Liggett SB
    Clin Transl Sci; 2008 Dec; 1(3):255-62. PubMed ID: 20443857
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Adrenergic Receptor Gene Polymorphisms and its Relationship with Heart Failure.
    Kolovou G; Kolovou V; Mavrogeni S
    Curr Vasc Pharmacol; 2018; 16(6):624. PubMed ID: 29210659
    [No Abstract]   [Full Text] [Related]  

  • 23. β-Arrestin as a Therapeutic Target in Heart Failure.
    Boussi L; Frishman WH
    Cardiol Rev; 2021 Sep-Oct 01; 29(5):223-229. PubMed ID: 33093306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reciprocal in vivo regulation of myocardial G protein-coupled receptor kinase expression by beta-adrenergic receptor stimulation and blockade.
    Iaccarino G; Tomhave ED; Lefkowitz RJ; Koch WJ
    Circulation; 1998 Oct; 98(17):1783-9. PubMed ID: 9788834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential future therapies for heart failure: gene transfer of beta-adrenergic signaling components.
    Maurice JP; Koch WJ
    Coron Artery Dis; 1999 Sep; 10(6):401-5. PubMed ID: 10474791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure.
    Anzai T; Lai NC; Gao M; Hammond HK
    Am J Physiol; 1998 Oct; 275(4):H1267-73. PubMed ID: 9746475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adrenergic receptor polymorphisms in heart failure: what can genetics explain?
    Pereira SB; Gava IA; Giro C; Mesquita ET
    Arq Bras Cardiol; 2010 Jun; 94(6):841-9. PubMed ID: 20625643
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The beta-adrenergic receptors.
    Wallukat G
    Herz; 2002 Nov; 27(7):683-90. PubMed ID: 12439640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beta-adrenergic receptor trafficking by exercise in rat adipocytes: roles of G-protein-coupled receptor kinase-2, beta-arrestin-2, and the ubiquitin-proteasome pathway.
    Ogasawara J; Sanpei M; Rahman N; Sakurai T; Kizaki T; Hitomi Y; Ohno H; Izawa T
    FASEB J; 2006 Feb; 20(2):350-2. PubMed ID: 16368719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure.
    Feldman DS; Carnes CA; Abraham WT; Bristow MR
    Nat Clin Pract Cardiovasc Med; 2005 Sep; 2(9):475-83. PubMed ID: 16265588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioligand Binding to Quantify Adrenergic Receptor Expression in the Heart.
    Grisanti LA
    Curr Protoc; 2023 Jan; 3(1):e649. PubMed ID: 36602296
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
    Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
    Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins.
    Kompa AR; Gu XH; Evans BA; Summers RJ
    J Mol Cell Cardiol; 1999 Jun; 31(6):1185-201. PubMed ID: 10371694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intact beta-adrenergic response and unmodified progression toward heart failure in mice with genetic ablation of a major protein kinase A phosphorylation site in the cardiac ryanodine receptor.
    Benkusky NA; Weber CS; Scherman JA; Farrell EF; Hacker TA; John MC; Powers PA; Valdivia HH
    Circ Res; 2007 Oct; 101(8):819-29. PubMed ID: 17717301
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of beta-adrenergic receptors in heart failure.
    Liggett SB
    Am J Med; 2004 Oct; 117(7):525-7. PubMed ID: 15464712
    [No Abstract]   [Full Text] [Related]  

  • 37. Adrenergic regulation of myocardial apoptosis.
    Singh K; Communal C; Sawyer DB; Colucci WS
    Cardiovasc Res; 2000 Feb; 45(3):713-9. PubMed ID: 10728393
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Beta-adrenergic receptors and receptor signaling in heart failure.
    Post SR; Hammond HK; Insel PA
    Annu Rev Pharmacol Toxicol; 1999; 39():343-60. PubMed ID: 10331088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GRK2 inhibition in heart failure: something old, something new.
    Lymperopoulos A; Rengo G; Koch WJ
    Curr Pharm Des; 2012; 18(2):186-91. PubMed ID: 22229578
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beta-adrenergic signaling in heart failure-adapt or die.
    Eschenhagen T
    Nat Med; 2008 May; 14(5):485-7. PubMed ID: 18463653
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.